Recent review of neurological drugs and current situation of multi–regional clinical trial

Abstract

Considering the globalization of new drug development, the current situation of multi–regional clinical trial is addressed. Recent review example of neurological drug is also introduced. In addition, recent challenges of PMDA to promote development of neurological drug/medical devices and expectation for academia are discussed.